Today :

Cangzhou Central Hospital


Internal Medicine-Neurology six

Internal Medicine-Neurology six is the nerve for the treatment of nervous system diseases based set of medical, teaching, scientific research, prevention one department. Kone, the existing staff of more than 20 people. 1 doctors of director, deputy chief physician 2, 3 physicians, 6 postgraduates. Wang Huanjun director for the Hebei Province outstanding contributions of young scholars; Cangzhou City top-notch professional and technical personnel.

Internal Medicine-Neurology six good at Carotid artery thrombolytic therapy at cerebral infarction, intervention in the treatment of recurrent hemorrhage of hypertensive cerebral hemorrhage

Interventional therapy of cerebrovascular disease; facial neuralgia, brain and spinal cord infection disease, Parkinson's disease, epilepsy treatment of various diseases; dementia; psychological disorders; and development of neural stem cells transplantation.

Wrote and published 6 monographs, published more than 62 papers, 5 patents have been national patent, and in the clinical application. Obtain 8 items of scientific and technological achievements, municipal science and technology progress award 6.

The main research of the "super early carotid artery thrombolysis for acute cerebral infarction study"; "LVC on hypertensive cerebral hemorrhage bleeding intervention study"; image head SAH CT classification of intracranial aneurysms embolization therapy "," LVC of hypertensive cerebral hemorrhage by re intervention study ";" study on acute cerebral infarction treated with small dose carotid artery repeatedly urokinase thrombolysis". "Atorvastatin and cerebral ultrasonic therapy intervention research" on the fatty plaque of carotid artery and other seven research has won the Hebei Province scientific and technological achievements and province, city science and technology progress award. The national five year project "since 2012 to assume the cerebrovascular disease two grade prevention scheme optimization and Application Research", has completed the case into the group stages, administration, case inspection, has entered the medium-term work.

Specialty: 1 carotid artery thrombolysis for acute cerebral infarction; 2 interventional therapy of cerebral vascular disease: cerebrovascular stent angioplasty and endovascular embolization of cerebral aneurysm; 3 cerebral ultrasonic therapy on cerebral vascular disease; 4, neural stem cell therapy; 5 cerebrospinal fluid cytology diagnosis of brain and spinal cord disease; comprehensive treatment of 6 facial neuralgia.




Do not reprint, editing or use other ways to use this website without the authorization of the station
Copyright © 2014 Cangzhou Central Hospital